<html>
<head>PUBMED IDs for BAZ2A</head>
<body bgcolor='#C5F0F2'><h1>BAZ2A</h1><a href='https://pubmed.ncbi.nlm.nih.gov/10662543/'>A novel family of bromodomain genes.</a> February 9  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/16643428/'>Fusion of ETV6 with an intronic sequence of the BAZ2A gene in a paediatric pre-B acute lymphoblastic leukaemia with a cryptic chromosome 12 rearrangement.</a> April 29  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16643399/'>Progressive cardiac conduction defect is the prevailing phenotype in carriers of a Brugada syndrome SCN5A mutation.</a> April 29  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/19667409/'>Truncation of histone H2A's C-terminal tail, as is typical for Ni(II)-assisted specific peptide bond hydrolysis, has gene expression altering effects.</a> December 16  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/25485837/'>BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence.</a> March 12  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25799074/'>Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2B.</a> July 28  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25916849/'>A novel RNA binding surface of the TAM domain of TIP5/BAZ2A mediates epigenetic regulation of rRNA genes.</a> August 19  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/28587163/'>A Tox21 Approach to Altered Epigenetic Landscapes: Assessing Epigenetic Toxicity Pathways Leading to Altered Gene Expression and Oncogenic Transformation In Vitro.</a> June 8  2017<br></body></html>
